随着The Oncology Institute, Inc. (NASDAQ: TOI)高管团队的变动,投资者和利益相关者正密切关注公司的财务状况和市场地位。根据InvestingPro数据,TOI目前的市值为2212万美元。虽然该公司在截至2024年第二季度的过去十二个月内实现了23.31%的可观收入增长,但值得注意的是,TOI在同期并未盈利,营业利润率为-17.62%。
He brings a wealth of experience in both oncology and large health systems, has been instrumental to our finance operations over the last several years, and is the right leader for the next phase of ...